Physician profile
Christopher C Reynolds
NPI 1366705543
$22,097.17
in general payments reported to CMS, 2019-2025
21 companies · $18K in 2025
The $18K reported for 2025 was more than what 99% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $402 · 2020: $296 · 2021: $233 · 2022: $991 · 2023: $1,164 · 2024: $1,131 · 2025: $18K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $13K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,750 · Food and Beverage: $2,718 · Travel and Lodging: $1,506.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $13,200.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,750.00 |
| Food and Beverage | $2,718.45 |
| Travel and Lodging | $1,506.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $17,967.72 | 2022-2025 | Igt Devices Undivided, Igt Devices Systems Undivided, (9124) Lm Undivided |
| Abbott Laboratories | $1,292.97 | 2021-2025 | Viewmate, Ensite, Aveir |
| Boston Scientific Corporation | $862.69 | 2021-2025 | Watchman Access System, Ingevity Mri, Bodyguardian |
| Medical Device Business Services, INC. | $568.98 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $421.97 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $219.51 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $155.82 | 2023-2024 | Jardiance |
| Cvrx, INC. | $149.86 | 2022-2023 | Barostim Neo System |
| Pfizer INC. | $67.26 | 2023-2025 | |
| Amgen INC. | $50.32 | 2021-2022 | |
| Irhythm Technologies, INC. | $49.18 | 2024 | Zio Xt Patch, Zio Monitor |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $47.40 | 2024 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $45.01 | 2019-2021 | |
| Astrazeneca Pharmaceuticals Lp | $36.67 | 2023-2024 | Andexxa |
| Alexion Pharmaceuticals, INC. | $33.70 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $31.67 | 2023 | Vectra, Conduit, Symphony |
| Allergan, INC. | $27.22 | 2020 | |
| Csl Behring | $22.23 | 2022 | |
| Abbvie INC. | $20.97 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $15.27 | 2023 | |
| Lemaitre Vascular, INC. | $10.75 | 2023 | Artegraft Vascular Graft |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Reynolds listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.